Lassègue B - Search Results

1

Angiotensin receptors and their therapeutic implications.

Griendling KK, Lassègue B, Alexander RW. Griendling KK, et al. Among authors: lassegue b. Annu Rev Pharmacol Toxicol. 1996;36:281-306. doi: 10.1146/annurev.pa.36.040196.001433. Annu Rev Pharmacol Toxicol. 1996. PMID: 8725391 Review.

2

Polymerase δ-interacting Protein 2: A Multifunctional Protein.

Hernandes MS, Lassègue B, Griendling KK. Hernandes MS, et al. Among authors: lassegue b. J Cardiovasc Pharmacol. 2017 Jun;69(6):335-342. doi: 10.1097/FJC.0000000000000465. J Cardiovasc Pharmacol. 2017. PMID: 28574953 Free PMC article. Review.

3

Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.

Lassègue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Lassègue B, et al. Mol Pharmacol. 1995 Oct;48(4):601-9. Mol Pharmacol. 1995. PMID: 7476884

4

Angiotensin II receptor pharmacology.

Griendling KK, Lassègue B, Murphy TJ, Alexander RW. Griendling KK, et al. Among authors: lassegue b. Adv Pharmacol. 1994;28:269-306. doi: 10.1016/s1054-3589(08)60498-6. Adv Pharmacol. 1994. PMID: 8080819 Review. No abstract available.

5

The vascular angiotensin (AT1) receptor.

Griendling KK, Lassègue B, Alexander RW. Griendling KK, et al. Among authors: lassegue b. Thromb Haemost. 1993 Jul 1;70(1):188-92. Thromb Haemost. 1993. PMID: 8236101 Review. No abstract available.

6

Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation.

Ishizaka N, Griendling KK, Lassègue B, Alexander RW. Ishizaka N, et al. Among authors: lassegue b. Hypertension. 1998 Sep;32(3):459-66. doi: 10.1161/01.hyp.32.3.459. Hypertension. 1998. PMID: 9740611

7

Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells.

Ushio-Fukai M, Alexander RW, Akers M, Lyons PR, Lassègue B, Griendling KK. Ushio-Fukai M, et al. Among authors: lassegue b. Mol Pharmacol. 1999 Jan;55(1):142-9. doi: 10.1124/mol.55.1.142. Mol Pharmacol. 1999. PMID: 9882708

8

Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells.

Grant SL, Lassègue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW. Grant SL, et al. Among authors: lassegue b. Mol Pharmacol. 2000 Mar;57(3):460-7. doi: 10.1124/mol.57.3.460. Mol Pharmacol. 2000. PMID: 10692485

9

Reactive oxygen species in hypertension; An update.

Lassègue B, Griendling KK. Lassègue B, et al. Am J Hypertens. 2004 Sep;17(9):852-60. doi: 10.1016/j.amjhyper.2004.02.004. Am J Hypertens. 2004. PMID: 15363831 Review.

10

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice.

Dikalova A, Clempus R, Lassègue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, Griendling KK. Dikalova A, et al. Among authors: lassegue b. Circulation. 2005 Oct 25;112(17):2668-76. doi: 10.1161/CIRCULATIONAHA.105.538934. Epub 2005 Oct 17. Circulation. 2005. PMID: 16230485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page